Collegium Pharmaceutical, Inc.
NASDAQCollegium Pharmaceutical enters the final stretch of Q3 with a fresh bull on the Street and short sellers steadily closing positions — yet the stock trades at $22.78, less than half where analysts think it belongs. Oppenheimer initiated coverage this morning with an Outperform rating and a $50 price target, adding to a consensus that is uniformly constructive. Every analyst…
Snapshot as of 4 Oct 2026
Collegium Pharmaceutical enters the final stretch of Q3 with a fresh bull on the Street and short sellers steadily closing positions — yet the stock trades at $22.78, less than half where analysts think it…
Collegium Pharmaceutical enters the back half of August with a charged setup — a stock down 21% in a month, short interest at multi-year highs, and options traders flipping sharply bullish even as bears rebuild…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for COLL — free to start on ORTEX.
Sign up for free →Open COLL on ORTEX